Intracranial hypertension (IH), a clinical condition typically seen in the intensive care unit, is caused by increased pressure surrounding the brain. In many situations, the cause of chronic IH is ...

For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional ...

"IIH is a rapidly increasing health care concern for the US population," the investigators wrote. They noted that IIH treatments are limited making it difficult to manage the often-debilitating ...

Int Ophthalmol Clin. 2014;54(1):103-114. Topiramate is typically started at 25 mg daily and can be titrated up to 100 mg twice daily. It is frequently given in addition to acetazolamide in the ...

A new study led by investigators from Mass General Brigham shows that a brain waste- "clean-up" system is influenced by intracranial pressure. The system, called the glymphatic system, was ...

If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this disorder can develop without noticeable symptoms, making it hard to catch.

Doctors think they've figured out a way to predict who might lose vision due to a high brain pressure disorder. Idiopathic intracranial hypertension occurs when there's unexplained pressure buildup in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Idiopathic intracranial hypertension is prevalent among ...

Please provide your email address to receive an email when new articles are posted on . Patients with idiopathic intracranial hypertension can be managed medically. For surgical management, consider ...